Berman Bettina, Friedman Craig D
Jefferson School of Population Health, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Facial Plast Surg. 2010 Aug;26(4):283-8. doi: 10.1055/s-0030-1262310. Epub 2010 Jul 27.
The United States spends more per capita for health care than any other nation in the world. Unfortunately, this expenditure has not necessarily translated into improved patient outcomes. Technological advances coupled with an aging population have contributed to a steady increase in health care spending, projected to have reached $2.5 trillion in 2009. Until recently, facial plastic surgeons have not given attention to value-based purchasing and pay-for-performance paradigms, perceiving these quality agendas as primarily applicable to primary care physicians and chronic disease management. As the use of quality measure factors in physician reimbursement schemes for primary medical care becomes more prevalent, it is imperative that surgical specialists have better insight and knowledge of these trends and their impact. This review will define quality and outcomes parameters in conjunction with an analysis of how outcomes may, in the future, be attached to reimbursement for facial plastic surgeons. Illustration of common facial plastic surgery procedures and potential quality/outcome/performance schema will highlight key elements to assist these surgeons in preparing for the transformation of the health care system to quality and outcomes metrics.
美国人均医疗保健支出高于世界上任何其他国家。不幸的是，这种支出并不一定会转化为患者治疗效果的改善。技术进步加上人口老龄化导致医疗保健支出稳步增加，预计2009年已达到2.5万亿美元。直到最近，面部整形外科医生还没有关注基于价值的采购和按绩效付费模式，认为这些质量议程主要适用于初级保健医生和慢性病管理。随着质量衡量因素在初级医疗保健医生报销计划中的使用越来越普遍，外科专科医生必须更好地了解这些趋势及其影响。本综述将结合分析未来面部整形外科医生的报销如何与治疗效果挂钩，来定义质量和治疗效果参数。常见面部整形手术程序及潜在的质量/治疗效果/绩效模式的说明将突出关键要素，以帮助这些外科医生为医疗保健系统向质量和治疗效果指标的转变做好准备。
